[ad_1]
“We see the effect of such treatment: the need for additional oxygen decreases, the inflammatory indicators decrease.” There were also no side effects, ”explained Lina Kryžauskaitė, director of the Blood Center.
However, he stressed that the benefits of such treatment were not yet fully scientifically substantiated and that the currently available data should be treated with caution.
“There are no final results, statistically significant data to support a definitive benefit, by the way, as with other COVID-19 treatments. Now that investigation is being carried out, ”said the doctor.
According to her, in total around 35 thousand people have been treated with this treatment in the world so far. patients.
L. Kryžauskaitė pointed out that not all patients can be treated in this way.
“In order to transfer plasma, a decision must be made during a consultation with doctors. The need for additional oxygen, the availability of other treatments and other criteria is evaluated,” he said.
Approximately 100 COVID-19 patients have agreed to be plasma donors in Lithuania since the start of the pandemic. Of these, around 20 donated blood at least twice.
He also emphasized that blood can only be given after at least 30 days have passed since the onset of symptoms.
According to L. Kryžauskaitė, not only the sick, but also healthy people are invited to donate blood, because after the resumption of planned operations, it quickly began to be absent.
[ad_2]
